A pharmacogenetic study of response to a 5-lipoxygenase inhibitor in a Phase II clinical trial.

被引:0
|
作者
Lewitzky, S
Barnes, G
Garg, P
Metivier, J
Chang, M
Rosengren, B
Meyer, J
机构
[1] Millennium Pharmaceut Inc, Dept Clin Dev, Cambridge, MA USA
[2] Millennium Pharmaceut Inc, Dept Mol & Cellular Pharmacol, Cambridge, MA USA
[3] Millennium Pharmaceut Inc, Dept Mol Epidemiol, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
1288
引用
收藏
页码:390 / 390
页数:1
相关论文
共 50 条
  • [41] KINETICS AND MECHANISM OF DEGRADATION OF ZILEUTON, A POTENT 5-LIPOXYGENASE INHIBITOR
    ALVAREZ, FJ
    SLADE, RT
    PHARMACEUTICAL RESEARCH, 1992, 9 (11) : 1465 - 1473
  • [42] EFFECT OF 5-LIPOXYGENASE INHIBITOR ON EXPERIMENTAL DELAYED CEREBRAL VASOSPASM
    YOKOTA, M
    TANI, E
    MAEDA, Y
    KOKUBU, K
    STROKE, 1987, 18 (02) : 512 - 518
  • [43] A fast and efficient method for the preparation of the 5-lipoxygenase inhibitor myxochelin A
    Schieferdecker, Sebastian
    Nett, Markus
    TETRAHEDRON LETTERS, 2016, 57 (12) : 1359 - 1360
  • [44] A PRENYLFLAVONE, ARTONIN-E, AS ARACHIDONATE 5-LIPOXYGENASE INHIBITOR
    REDDY, GR
    UEDA, N
    HADA, T
    SACKEYFIO, AC
    YAMAMOTO, S
    HANO, Y
    AIDA, M
    NOMURA, T
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (01) : 115 - 118
  • [45] Homology modeling of 5-lipoxygenase and hints for better inhibitor design
    P. Aparoy
    R. N. Reddy
    Lalitha Guruprasad
    M. R. Reddy
    P. Reddanna
    Journal of Computer-Aided Molecular Design, 2008, 22 : 611 - 619
  • [46] Synthesis of ML-3000, an inhibitor of cyclooxygenase and 5-lipoxygenase
    Cossy, J
    Belotti, D
    JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (23): : 7900 - 7901
  • [47] Potent dual 5-lipoxygenase inhibitor and PAF receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (09) : 424 - 424
  • [48] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
    HSIAO, CN
    KOLASA, T
    TETRAHEDRON LETTERS, 1992, 33 (19) : 2629 - 2632
  • [49] Lipidosis induced in the dog gallbladder by a direct 5-lipoxygenase inhibitor
    MolonNoblot, S
    Gillet, JP
    DurandCavagna, G
    Huber, AC
    Patrick, DH
    Duprat, P
    TOXICOLOGIC PATHOLOGY, 1996, 24 (02) : 231 - 237
  • [50] CGS 22745 - A SELECTIVE ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE
    KIMBLE, E
    KOWALSKI, T
    WHITE, D
    RAYCHAUDURI, A
    PASTOR, G
    CHERTOCK, H
    LEE, W
    NEALE, R
    HAMDAN, A
    WASLEY, J
    AGENTS AND ACTIONS, 1991, 34 (1-2): : 125 - 128